Scheduling of tramadol and exemptions for temazepam prescriptions
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
This consultation has concluded
Download the full outcome
Detail of outcome
This document combines the summary of responses and the government responses to each of the proposals.
The government has considered the concerns raised in the consultation and has decided to place tramadol in Schedule 3 to the Misuse of Drugs Regulations 2001 when it is controlled later this year, but with exemption from the safe custody requirements.
The government assesses that on the available evidence, the existing exemption for temazepam prescriptions are no longer warranted and has decided, in principle, to implement legislative changes to remove the exemption, subject to advice from the Advisory Council on the Misuse of Drugs.
This consultation ran from
Consultation on the scheduling of tramadol and a review of exemptions for temazepam prescriptions under Misuse of Drugs Regulations 2001.
PDF, 221KB, 16 pages
PDF, 255KB, 14 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This consultation seeks your views on the ACMD’s recommendation to place tramadol in Schedule 3 to the Misuse of Drugs Regulations 2001 (as amended) following control under the Misuse of Drugs Act 1971. Tramadol is currently a prescription only medicine.
The consultation also seeks your views on the continued application of current exemptions for prescriptions for the Schedule 3 drug temazepam. These proposals have been prepared in discussion with the ACMD and the Department of Health.
This consultation is not seeking views on whether tramadol should be controlled under the Misuse of Drugs Act 1971.
This consultation applies to the whole of the United Kingdom, including Northern Ireland.
Responses should arrive no later than 11 October 2013.
Please send us your comments by using our online form
Alternatively, you can email your response to: DrugLegislationConsultations@homeoffice.gsi.gov.uk
Or write to:
Drug Legislation Team
Drugs and Alcohol Unit
4th Floor, Fry
2 Marsham Street
LONDON SW1P 4DF